… and serum albumin levels. … humans and WN rats, since the co-solvents used in the solution
formulation may have prevented pre-systemic drug loss due to the low solubility of erlotinib. …

… CL block copolymers which used in encapsulation of bovine serum albumin(BSA), taxol and
… with different concentration of erlotinib solution and drug loaded nanoparticles are shown in …

… By using human serum albumin (HSA)-bound paclitaxel (PTX) as the model nanomedicine
drug, it is found that erlotinib treatment could greatly enhance the efficacy of nanoparticle-…

… the serum phenytoin level before the introduction of erlotinib. … low serum albumin level in
this patient. Accordingly, it is highly possible that the introduction of erlotinib lowered the serum …

… Unspecific binding was blocked by bovine serum albumin at 3 mg/… The human plasma
concentration considered to be safe (… The co-medication, mode of application and the application …

… The area under the drug concentration-time curve of pleural fluid for erlotinib was 28,406
ng-… using blank human plasma and MPE samples from different donors. Blood samples were …

… high in vitro stability in human serum up to 48 h. They … drug itinerary for tyrosine kinase
receptor targeted therapy of patients.9, 10, 11 Here in this report analogues of the TKI erlotinib …

… Shen and Li developed erlotinib loaded hyaluronic acid and human serum albumin co-modified
NPs (ERT-HSA-HA NPs) by applying the precipitation method [65]. The mean particle …

… NC membrane was blocked with 5% bovine serum albumin (BSA) in triethanolamine … To
dissect the details regarding the vessel normalization dynamics after drug administration, we …

… Erlotinib is now used as an antineoplastic drug in the treatment of NSCLC in over 90 countries.
In Japan, erlotinib … of erlotinib is considered to be bound to human serum albumin and …